Samuel Herschkowitz

Samuel Herschkowitz

Director/Board Member chez ACERUS PHARMACEUTICALS CORPORATION

74 ans
Health Technology
Consumer Services
Finance

Profil

Samuel Herschkowitz was the founder of Serenity Pharmaceuticals Corp.
(founded in 2007), where he held the title of Chief Executive Officer & Chairman from 2007 to 2022.
He is also the founder of Serenity Pharmaceuticals LLC.
Currently, he holds the position of Vice Chairman at Acerus Pharmaceuticals Corp.
and is a Professor at NYU Langone Health.
In the past, he held the position of Chief Executive Officer & Director at Prospect Park Capital Corp.
from 2012 to 2020 and was the Chief Operating & Technical Officer, Director at Delcath Systems, Inc. from 1988 to 2007.
Dr. Herschkowitz received his undergraduate degree from Syracuse University in 1971 and his doctorate degree from the State University of New York at Downstate Medical Center in 1976.

Postes actifs de Samuel Herschkowitz

SociétésPosteDébut
ACERUS PHARMACEUTICALS CORPORATION Director/Board Member -
Corporate Officer/Principal -
Chief Executive Officer -
Tous les postes actifs de Samuel Herschkowitz

Anciens postes connus de Samuel Herschkowitz

SociétésPosteFin
Chief Executive Officer 01/02/2022
PROSPECT PARK CAPITAL CORP. Chief Executive Officer 23/01/2020
DELCATH SYSTEMS, INC. Chief Tech/Sci/R&D Officer 17/06/2007
Voir l'expérience en détail de Samuel Herschkowitz

Formation de Samuel Herschkowitz

Syracuse University Undergraduate Degree
State University of New York at Downstate Medical Center Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Samuel Herschkowitz

Relations

100 +

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
DELCATH SYSTEMS, INC.

Health Technology

PROSPECT PARK CAPITAL CORP.

Finance

Entreprise privées4

Health Technology

Health Technology

Technology Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Samuel Herschkowitz